Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Integra Lifesciences Holdings Corp shares valued at $305,492 were sold by DAVIS ROBERT T. JR. on Mar 06 ’24. At $36.59 per share, DAVIS ROBERT T. JR. sold 8,348 shares. The insider’s holdings dropped to 49,893 shares worth approximately $1.7 million following the completion of this transaction.
Also, Mosebrook Jeffrey sold 1,177 shares, netting a total of over 52,329 in proceeds. Following the sale of shares at $44.46 each, the insider now holds 23,458 shares.
Before that, De Witte Jan had added 7,792 shares to its account. In a trade valued at $299,986, the President & CEO bought Integra Lifesciences Holdings Corp shares for $38.50 each. Upon closing the transaction, the insider’s holdings increased to 7,792 shares, worth approximately $0.44 million.
As published in a research note from Citigroup on April 03, 2024, Integra Lifesciences Holdings Corp [IART] has been rated up from a Sell to a Neutral and the price target has been revised to $38. Analysts at Wells Fargo upgraded the stock from ‘”an Equal weight”‘ to ‘”an Overweight”‘ outlook in a report released in early December. As of November 14, 2023, CL King has initiated its “Buy” rating for IART. Earlier on August 24, 2023, Morgan Stanley downgraded its rating. Their new recommendation was “an Underweight” for IART stock which previously was a “an Equal-weight”.
Analyzing IART Stock Performance
During the last five days, there has been a surge of approximately 0.53%. Over the course of the year, Integra Lifesciences Holdings Corp shares have dropped approximately -21.75%. Shares of the company reached a 52-week high of $45.42 on 02/20/24 and a 52-week low of $33.24 on 03/25/24. A 50-day SMA is recorded $38.16, while a 200-day SMA reached $40.23. Nevertheless, trading volume fell to 0.63 million shares from 0.49 million shares the previous day.
Support And Resistance Levels for Integra Lifesciences Holdings Corp (IART)
According to the 24-hour chart, there is a support level at 33.66, which, if violated, would cause prices to drop to 33.25. In the upper region, resistance lies at 34.29. The next price resistance is at 34.50. RSI (Relative Strength Index) is 39.56 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.18, which suggests the price will decrease in the coming days. Percent R is at 62.53%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
Is Integra Lifesciences Holdings Corp subject to short interest?
Stocks of Integra Lifesciences Holdings Corp saw a sharp steep in short interest on Mar 15, 2024 dropping by -0.28 million shares to 2.21 million. Data from Yahoo Finance shows that the short interest on Feb 15, 2024 was 2.49 million shares. A decline of -12.67% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 2.55 of the overall float, the days-to-cover ratio (short ratio) decline to 2.55.
